Curcumin Market Drivers Shaping Future Growth, Revenue $104.19 Million by 2025 | CAGR 8.9%
The global curcumin market was valued at $52.45 million in 2017, and is projected to reach $104.19 million by 2025, registering a CAGR of 8.9% from 2018 to 2025. In 2017, the pharmaceutical segment accounted for more than 50% share of the global curcumin market in terms of value.
Download Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/4752
Curcumin is a bioactive compound found in
turmeric, known for its powerful medicinal and therapeutic properties. It has
been used as a spice and medicinal herb for thousands of years in Asian
countries such as India, Thailand, Indonesia, and others. Owing to its
anti-inflammatory, antioxidant, and cartilage building properties curcumin
finds extensive applications in the cosmetic and pharmaceutical industry.
Medicines containing curcumin extracts are used for treatment of numerous
diseases and health problems such as wound healing, treating sprains,
arthritis, liver problems, diabetes, gastric problems, Alzheimer, and migraine.
Curcumin extracts have been formulated in many skincare applications in the
form of skin creams, ointments, powder, and others. It helps to heal and
prevent dry skin, treat skin conditions such as eczema and acne, and delay the
aging process. Thus, the increase in use of curcumin in cosmetic and
pharmaceutical industry has propelled the curcumin market growth in recent
years.
Leading market players analyzed in the research
include Phyo life Sciences, Konark Herbals & Health Care, BioThrive
Sciences, SV Agrofood, Arjuna Natural Extracts Ltd., NOW Foods, Herboveda India
Pvt. Ltd., Star Hi Herbs Pvt. Ltd.,Biomax Life Sciences Ltd. andSynthite
Industries Ltd.
Buy This Report (263 Pages PDF with
Insights, Charts, Tables, and Figures): https://www.alliedmarketresearch.com/checkout-final/03a7e602529ff6d3646ee01c57ab9023
Covid-19 scenario:
- Due to lockdown in several countries, the cosmetics and food
& beverage manufacturers have completely shut down their operation.
Thus, the demand for curcumin is expected to decline for a few months due
to the Covid-19 pandemic outbreak and amid lockdown.
- The demand for curcumin is likely to experience a downfall
during the coronavirus pandemic due to the negatively-affected supply
chain amid lockdown.
- The revenue generated from the pharmaceutical segment will
increase significantly due to growing demand for ayurvedic medicines to
increase human immunityto fight against COVID-19 infection and other
diseases.
The report offers detailed segmentation of
the global curcumin market based on application and region. Based on
application, the pharmaceutical segment contributed to the largest share in
2019, accounting for more than half of the total share, and is estimated to
maintain its dominant position during the forecast period. However, the food
& beverage segment is estimated to portray the highest CAGR of 9.5% during
the forecast period.
Request
For Customization https://www.alliedmarketresearch.com/request-for-customization/4752
Based on region, North America contributed
the highest share, accounting formore than halfof the total market share in
2017, and will maintain its dominance throughout the forecast period. However,
Europe is expected to grow at the highest CAGR of 9.5% from 2018 to 2025.
Comments
Post a Comment